Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 22.4M | 16.5M | — | 13.9M |
| Cost of revenue | 10.7M | 9.0M | — | 6.7M |
| Gross profit | 11.8M | 7.5M | — | 7.2M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 7.7M | -11.0M | — | 4.6M |
| Operating income | 2.1M | 2.9M | — | 1.8M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.9M | 3.1M | — | 1.6M |
| Tax provision | 661.6K | 627.9K | — | 552.6K |
| Net income | 1.3M | 2.5M | — | 1.0M |
| Basic EPS | 0.0 | — | 0.1 | 0.0 |
| Diluted EPS | 0.0 | — | 0.1 | 0.0 |
| Basic average shares | 31.3M | — | 31.3M | 30.3M |
| Diluted average shares | 31.3M | — | 31.3M | 30.3M |
| EBITDA | 4.7M | 4.5M | — | 2.8M |
| Net income from continuing op. | 1.3M | 2.5M | — | 1.0M |
| Minority interests | 4.7K | — | — | 912 |
| Preferred stock dividends | 0 | 0 | — | 0 |